Digital pathology is rapidly reshaping diagnostic workflows worldwide. Whole-slide imaging, remote collaboration and AI-driven analysis are becoming standard practice. Yet, the real value of this transformation only emerges when systems are truly interoperable.
As we enter in 2026, the key challenge is no longer digitization itself — but how to scale digital pathology through interoperable, future-proof architectures.
Interoperability as the foundation
One of the biggest adoption barriers has been technological fragmentation: scanners, viewers, storage platforms and AI tools operating in silos.
Recent industry analyses highlight that DICOM standards for Whole Slide Imaging (WSI) are now reaching a level of maturity that enables multi-vendor, production-ready interoperability. This shift allows laboratories and hospitals to move beyond proprietary constraints and toward integrated, flexible digital pathology ecosystems.
Standards and collaboration driving progress
Technology alone is not enough. Interoperability advances when standards, research and industry collaboration align.
A strong signal of this trend is the strategic alliance between the MICCAI Society and the European Society of Digital and Integrative Pathology (ESDIP), aimed at accelerating shared research, best practices and interoperable tools across the digital pathology community.
This reinforces a clear direction: the future of digital pathology is open, connected and collaborative.
Market growth reinforces the need for interoperability
Market data confirms this trajectory. According to recent industry reports, the digital pathology market is expected to grow at nearly 9.9% CAGR through 2031, driven largely by AI adoption and workflow digitalization.
This growth is only sustainable if interoperability is in place. AI models require standardized access to images and metadata — without it, innovation remains fragmented and difficult to scale.
Why digital pathology interoperability matters in 2026
- Clinical scalability: enabling collaboration across institutions.
- Operational efficiency: reducing custom integrations.
- AI readiness: supporting advanced analytics on standardized data.
- Future resilience: protecting investments against vendor lock-in.
Meditecs’ approach: digital pathology interoperability proven in real-world environments
At Meditecs, we believe that interoperability in digital pathology only delivers value when it works in real clinical environments — across multiple vendors, complex workflows, and without disrupting daily practice.
This approach was clearly demonstrated at the European Congress of Digital Pathology (ECDP) 2025, where we saw strong interest from industry leaders and innovative startups in DICOMPath, our IHE-compliant, first-in-class interoperability solution designed to seamlessly connect the entire digital pathology ecosystem.
Innovation was everywhere at ECDP 2025: from robotic scanners such as those from ARGOS Slide Scanner Systems, to AI-powered image management systems like PathPresenter, and advanced AI analyzers from Ibex Medical Analytics and aetherAI.
Yet the core challenge remains unchanged: making all these technologies work together in real-world clinical settings.
This is precisely where Meditecs DICOMPath plays a critical role — enabling smooth, vendor-neutral interoperability while preserving existing clinical workflows and aligning with international standards such as DICOM and IHE.
A key highlight was the technical exchange between Francisco José Carrasco Tena, Head of Development at Meditecs, and David Clunie, member and chair of the DICOM committee and co-chair of the IHE Radiology Technical Committee — widely recognized as the “father of DICOM”.
These discussions underline the importance of building interoperability on globally agreed standards rather than proprietary shortcuts.
During the Connectathon, Meditecs also achieved successful interoperability results with leading scanner and technology vendors, including: Leica Biosystems, 3DHISTECH, Hamamatsu Photonics Europe, Pramana, CitiusTech, and Hologic.
These outcomes confirm that digital pathology interoperability is no longer theoretical — it is achievable today when grounded in standards, clinical understanding, and ecosystem collaboration.
Our mission is to transform interoperability from a technical challenge into a clinical and strategic advantage.
Join the conversation
These challenges and strategies will be explored in depth in our upcoming webinar, bringing together experts from hospitals, laboratories and technology providers across Spain and Latin America.
👉 Learn how to make digital pathology truly interoperable in 2026
